Uğur Şahin - Wikipedia
Uğur Şahin (Turkish: [uˈuɾ ʃaː.hin]; born 19 September 1965 [2]) is a German medical researcher, entrepreneur, and businessman.
Searching…
Uğur Şahin (Turkish: [uˈuɾ ʃaː.hin]; born 19 September 1965 [2]) is a German medical researcher, entrepreneur, and businessman.
Prof. Ugur Sahin, M.D., Co-Founder and CEO of BioNTech, is a physician, immunologist and leader in the development of novel approaches to fight cancer and infectious diseases. Sahin is one of the world’s foremost expe...
1 day ago · Uğur Şahin is CEO and cofounder of German biotech firm BioNTech, which partnered with Pfizer to produce the first Covid-19 vaccine approved in the US. Şahin led BioNTech to start on a vaccine for...
By Brenda Baletti, Ph.D. The CEO of Germany’s BioNTech outearned all his fellow pharma CEOs in 2024, according to Fierce Pharma. Dr. Uğur Şahin’s nine-figure salary — $287 million — rocketed him to the top of the indu...
Jun 17, 2025 · BioNTech CEO tops Fierce Pharma’s list of Big Pharma’s 10 highest-paid CEOs. BioNTech’s Uğur Şahin took the No. 1 spot on Fierce Pharma’s list of the highest-paid pharma CEOs in 2024, raking in an indus...
Mar 10, 2025 · In exercising some of his stock options last year, BioNTech CEO Uğur Şahin, M.D., scored a whopping 259.5 million euros ($281 million) in calculated compensation.
BioNTech's Co-Founder and CEO is Ugur Sahin. Other executives include Jens Holstein, Chief Financial Officer; Sean Marett, Chief Business and Chief Commercial Officer and 4 others. See the full leadership team at Craft.
Prof. Dr. Ugur Sahin, MD, is the Chief Executive Officer and Co-Founder of BioNTech SE since 2008 and serves as its Member of Management Board since 2008 and serves as its Chair of the Management Board.
Prof. Ugur Sahin, M.D. is the CEO and Co-Founder at Biontech SE (BNTX). View complete executive profile, stock performance metrics, career history, and compensation details.
Jan 10, 2023 · COMIRNATY® (the Pfizer-BioNTech COVID-19 vaccine) has been granted standard marketing authorization (MA) by the European Commission to prevent coronavirus disease 2019 (COVID-19) in people aged 6 months...